Emcure Expands Poviztra® Use for MASH After CDSCO Approval
MM Desk
21 July, 2026
Emcure Pharmaceuticals Limited has expanded the use of its co-marketed brand Poviztra® following the approval
Emcure Pharmaceuticals Limited has expanded the use of its co-marketed brand Poviztra® following the approval
Emcure Pharmaceuticals Limited (BSE: 544210 | NSE: EMCURE) has announced the acquisition of the remaining